Anlotinib, Penpulimab and Capecitabine in Recurrent/Metastatic Nasopharyngeal Carcinoma

Inclusion criteria

• ✓. Blood routine should meet (No blood transfusion or blood product within the past 14 days, and no correction was used with G-CSF or other hematopoietic stimulating factors.):
• ✓. Hemoglobin (HB) ≥ 90g/L;
• ✓. White blood cell (WBC) ≥ 4\*109/L;
• ✓. Blood platelet (PLT): 100\_109/L;
• ✓. Biochemistry examination should meet:
• ✓. Total bilirubin (TBIL) ≤ 1.5\*upper limit of normal (ULN);
• ✓. Alanine transaminase (ALT) and aspartate transaminase (AST) ≤ 2.5\*ULN;
• ✓. Serum creatinine (Cr) ≤ 1.5×ULN and creatinine clearance (CCr) ≥ 60ml/min;